(Q36763724)

16 August 2017

1 reference

title

Bulimia nervosa treatment: a systematic review of randomized controlled trials (English)

1 reference

16 August 2017

1 reference

1 reference

6

Cynthia M Bulik

1 reference

16 August 2017

5

Kathleen N Lohr

1 reference

16 August 2017

Jennifer R Shapiro

1

1 reference

16 August 2017

Nancy D Berkman

series ordinal

2

1 reference

16 August 2017

Kimberly A Brownley

series ordinal

3

1 reference

16 August 2017

Jan A Sedway

series ordinal

4

1 reference

16 August 2017

1 May 2007

1 reference

International Journal of Eating Disorders

16 August 2017

1 reference

16 August 2017

40

1 reference

16 August 2017

4

1 reference

16 August 2017

321-336

1 reference

Empowerment of women with purging-type bulimia nervosa through nutritional rehabilitation.

16 August 2017

1 reference

Long-term outcome of antidepressant treatment for bulimia nervosa

21 January 2018

1 reference

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

21 January 2018

1 reference

Medication and psychotherapy in the treatment of bulimia nervosa

21 January 2018

1 reference

Three psychological treatments for bulimia nervosa. A comparative trial

21 January 2018

1 reference

Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy

21 January 2018

1 reference

Guided self-change for bulimia nervosa incorporating use of a self-care manual.

21 January 2018

1 reference

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

21 January 2018

1 reference

Review of the prevalence and incidence of eating disorders

21 January 2018

1 reference

7 January 2021

Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial

1 reference

7 January 2021

Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study

1 reference

7 January 2021

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

1 reference

7 January 2021

Sequencing of cognitive-behavioral treatments for bulimia nervosa

1 reference

7 January 2021

Engagement and outcome in the treatment of bulimia nervosa: first phase of a sequential design comparing motivation enhancement therapy and cognitive behavioural therapy.

1 reference

7 January 2021

Survival analysis of response to group psychotherapy in bulimia nervosa

1 reference

7 January 2021

Sequential treatment for bulimia nervosa incorporating a self-care manual

1 reference

7 January 2021

Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial

1 reference

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

7 January 2021

Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?

1 reference

7 January 2021

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

1 reference

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

7 January 2021

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.

1 reference

7 January 2021

A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

1 reference

7 January 2021

Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa

1 reference

7 January 2021

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.

1 reference

7 January 2021

Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.

1 reference

7 January 2021

A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome

1 reference

7 January 2021

The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa

1 reference

7 January 2021

Treatment of bulimia nervosa in a primary care setting

1 reference

7 January 2021

A randomized secondary treatment study of women with bulimia nervosa who fail to respond to CBT.

1 reference

7 January 2021

Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change

1 reference

7 January 2021

A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa.

1 reference

7 January 2021

The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa

1 reference

7 January 2021

Comparison of group and individual cognitive-behavioral therapy for patients with bulimia nervosa

1 reference

7 January 2021

A comparison of two psychological treatments for bulimia nervosa: Implications for models of maintenance

1 reference

7 January 2021

Cognitive therapy, nutritional therapy and their combination in the treatment of bulimia nervosa

1 reference

7 January 2021

The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa

1 reference

7 January 2021

Dialectical behavior therapy for bulimia nervosa.

1 reference

7 January 2021

Stage of change as a predictor of response to psychotherapy for bulimia nervosa

1 reference

7 January 2021

Predictors of 1-year treatment outcome in bulimia nervosa

1 reference

7 January 2021

Role of exposure with response prevention in cognitive-behavioral therapy for bulimia nervosa: three-year follow-up results

1 reference

7 January 2021

A Comparison of Nutritional Management with Stress Management in the Treatment of Bulimia Nervosa

1 reference

7 January 2021

Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa

1 reference

7 January 2021

Self-Help for Bulimia Nervosa: A Randomized Controlled Trial

1 reference

7 January 2021

Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study

1 reference

7 January 2021

A randomized controlled trial of guided imagery in bulimia nervosa

1 reference

7 January 2021

A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy

1 reference

7 January 2021

Predictors of outcome for two treatments for bulimia nervosa: short and long-term.

1 reference

7 January 2021

A comparison of behavioral and cognitive-behavioral interventions for bulimia nervosa

1 reference

7 January 2021

Cognitive-behavioral and response-prevention treatments for bulimia nervosa

1 reference

7 January 2021

Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison

1 reference

7 January 2021

Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change

1 reference

7 January 2021

Predictors of 12-month outcome in bulimia nervosa and the influence of attitudes to shape and weight

1 reference

7 January 2021

Identifiers

DOI

10.1002/EAT.20372

1 reference

16 August 2017

1 reference